News | October 28, 2022
Vimta Labs posts consolidated PAT of Rs. 13.21 crores in Q2FY23
The company has posted net profit of Rs. 13.21 crores for the period ended September 30, 2022
The company has posted net profit of Rs. 13.21 crores for the period ended September 30, 2022
He also encouraged all G20 members to contribute their public keys to the proposed Global Federated Public Trust Directory for ensuring seamless worldwide mobility of people and goods
The team will also assist the state health departments in terms of public health measures, management guidelines and protocols to manage the increasing cases of Avian Influenza
It allows users to generate cell lines suitable for clinical development without their own starter cells, vectors or prior experience in the field.
The company has reported total income of Rs. 3109.77 crores during the period ended September 30, 2022
Frazier led the company for 10 years as President and Chief Executive Officer, from 2011 through 2021.
Oncodesign Services (ODS ), with 600 clients in 33 countries and 227 employees worldwide, provides services from target identification to hit-to-lead and lead optimization through to IND filing.
On the Capex front, the company has invested Rs. 416 crore in the first half and it is broadly in line with our guidance for the two years around Rs. 2,000 crore across all the subsidiaries and divisions
Gland Pharma Q2 FY2023 consolidated net profit up at Rs. 241.24 Cr
The CRL did not identify any outstanding scientific issues with the product.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
